Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
The Journal of Biological Chemistry|October 8, 2014
A role for stefin B (cystatin B) in inflammation and endotoxemiaKatarina Maher, Barbara Jerič Kokelj, Miha Butinar, et al.Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in miceLisa Sevenich, Uta Schurigt, Kathrin Sachse, et al.Cancer Research|May 19, 2006
Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancerOlga Vasiljeva, Anna Papazoglou, Achim Krüger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 19, 2020
Probody Therapeutic Design of 89Zr-CX-072 Promotes Accumulation in PD-L1-Expressing Tumors Compared to Normal Murine Lymphoid TissueDanique Giesen, Linda N Broer, Marjolijn N Lub-de Hooge, et al.Nano Letters|August 3, 2018
Crumpled Aluminum Hydroxide Nanostructures as a Microenvironment Dysregulation Agent for Cancer TreatmentMarat I Lerner, Georgy Mikhaylov, Alexey A Tsukanov, et al.Biological Chemistry|November 16, 2012
The proinflammatory cytokines interleukin-1α and tumor necrosis factor α promote the expression and secretion of proteolytically active cathepsin S from human chondrocytesDejan Caglič, Urška Repnik, Christopher Jedeszko, et al.Nature Nanotechnology|August 9, 2011
Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironmentGeorgy Mikhaylov, Ursa Mikac, Anna A Magaeva, et al.Cancer Research|September 16, 2022
A Probody T Cell-Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited ToxicityLeila M Boustany, Sherry L LaPorte, Laurie Wong, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
First-in-Human Study of the Biodistribution and Pharmacokinetics of 89Zr-CX-072, a Novel Immunopet Tracer Based on an Anti-PD-L1 ProbodyLaura Kist de Ruijter, Jahlisa S Hooiveld-Noeken, Danique Giesen, et al.Proceedings of the National Academy of Sciences of the United States of America|June 26, 2021
Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeuticIñaki Etxeberria, Elixabet Bolaños, Alvaro Teijeira, et al.Pageof 5